Caplin Point Lab Share Price

₹ 2,331.00

-₹45.10 (-1.9%)
1D
Last updated 30 Oct, 2026, 15:29 IST
NSE: CAPLIPOINT
|
Pharmaceuticals

Caplin Point Lab Share Price Today

As of 1 Nov 2026, Caplin Point Lab share price is ₹2,331.00. The stock opened at ₹2,377.40, compared to its previous close of ₹2,376.10. During today's trading session, Caplin Point Lab share price moved in the range of ₹2,310.00 to ₹2,422.40, with an average price of ₹2,366.20 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,500.30 and a high of ₹2,990.00. On the performance front, Caplin Point Lab share price has increased by 36.08% over the last six months and is up 14.53% on a year-on-year basis.

Share price over the last 1 day fell from 2381.80 to 2331.00, ranging between 2315.00 and 2421.80.
₹2,310.00
1.90% down today
₹2,422.40
1D LOW
1D HIGH

Caplin Point Lab Stock Insights

Latest Earning
Op Profit TrendUp by 5.52% QoQ
Latest Earning
Net Profit TrendUp by 3.59% QoQ
Latest Earning
Revenue TrendUp by 2.45% QoQ
Stock Performance
OutperformingBeat Nifty by 38.36 % in last 6 month
Shareholding Pattern
DIIDII decreased stake by 82.87%
Shareholding Pattern
FIIFII decreased stake by 0.60%
Caplin Point Lab stock performance
Open₹2,377.40
High₹2,422.40
Low₹2,310.00
Prev. close₹2,376.10
Caplin Point Lab trading activity
Volume1,28,339
Average traded price₹2,352.89
Last traded time03:29:56 30 Oct
Last traded quantity3
Circuit
L
H
₹1,860.50
₹2,790.70
52-week
L
H
₹1,500.30
₹2,990.00
Mkt Cap Cr
17,671.58
P/E
26.06
P/B
5.24
ROA
16.76%
ROE
17.88%
ROCE
22.3%
Quick Ratio
5.59
EV/EBITDA
18.49

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Caplin Point Lab has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Caplin Point Lab appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Caplin Point Lab revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,76,306.2184.09.64.7%11.42%11.37%0.7533.6
Laurus Labs1,29,242.6897.021.3311.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Caplin Point Lab Company Background

ISIN
INE475E01026
Sector Market Cap
₹ 17,671.58 Cr

Caplin Point Laboratories Limited is an India-based pharmaceutical company with a business model catering predominantly to emerging markets of Latin America and Africa. The Company has also entered regulated markets such as the United States through its Subsidiary, Caplin Steriles Limited. The Company's operations include research & development and manufacturing of finished formulations, active pharmaceutical ingredients (APIs), clinical research, front-end generic presence in Latin America, brand marketing in Francophone Africa and a USFDA/EU-GMP approved injectable facility. In the Regulated Markets, its products include liquid & lyophilized vials, pre-filled syringes, three-pc ophthalmic droppers and pre-mix bags. In the Emerging Markets, its products include tablets, dry syrups - bottles, soft gels, capsules, suppositories, liquid syrups - bottles, liquid injectables in ampoules & vials, lyophilized vials, prefilled syringes (PFS), and emulsion injection in ampoules & vials.

Caplin Point Lab Financial Highlights

  • Revenue: Caplin Point Lab reported revenue of ₹2,302.73 crore in FY26 vs ₹2,033.90 crore in FY25. It showed an increase of 13.22% on a yearly basis.
  • Operating Profit: Caplin Point Lab reported an operating profit of ₹802.79 crore in FY26 vs ₹676.78 crore in FY25. It showed an increase of 18.62% on a year-on-year basis.
  • Net Profit: Caplin Point Lab reported a net profit of ₹649.73 crore in FY26 vs ₹541.09 crore in FY25. It showed an increase of 20.08% on a yearly basis.

Caplin Point Lab Quarterly Result Highlights

  • Caplin Point Lab reported revenue of ₹643.91 crore in Jun 2026, compared with ₹628.52 crore in Mar 2026, representing an increase of 2.45% on a quarter-on-quarter (QoQ) basis.
  • Caplin Point Lab reported an operating profit of ₹225.22 crore in Jun 2026, compared with ₹213.44 crore in Mar 2026, representing an increase of 5.52% on a quarter-on-quarter (QoQ) basis.
  • Caplin Point Lab reported a profit of ₹179.09 crore in Jun 2026, compared with ₹172.88 crore in Mar 2026, reflecting an increase of 3.59% on a QoQ basis.
  • The earnings per share (EPS) of Caplin Point Lab stood at ₹84.36 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
70.57%
FII
5.72%
Other DII
0.08%
Retail and other
21.99%
Mutual funds
1.64%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20256.59%
Mar 20266.15%
Jun 20265.75%
Sep 20265.72%

Caplin Point Lab Investment Returns

1 day
-2.13%
1 week
+4.66%
1 month
-14.39%
1 year
+14.53%
3 years
+129.15%
5 years
+183.26%

Caplin Point Lab Share Price History

Caplin Point Lab share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
30 Oct 26
₹2,377.40 / ₹2,325.60
-2.13%
29 Oct 26
₹2,356.20 / ₹2,376.10
+0.56%
28 Oct 26
₹2,352.00 / ₹2,362.80
+0.44%
27 Oct 26
₹2,294.50 / ₹2,352.40
+3.45%
Show more

Caplin Point Lab Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,187.19₹1,937.47₹1,694.10₹1,466.73
Other Income₹115.54₹96.43₹66.94₹55.98
Total Revenue₹2,302.73₹2,033.90₹1,761.04₹1,522.71
Total Expenses₹1,499.98₹1,357.11₹1,196.88₹1,071.44
Profit Before Tax₹802.79₹676.78₹564.43₹451.35
Tax₹153.06₹135.69₹103.01₹74.36
Profit After Tax₹649.73₹541.09₹461.42₹376.99
EPS - Basic₹84.36₹70.57₹60.19₹49.62
EPS - Diluted₹84.11₹70.25₹59.90₹49.18

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹802.79₹676.78₹564.43₹451.35
Income before WC changes₹776.71₹682.29₹566.83₹463.12
Change in Assets-₹319.42-₹117.48-₹228.22-₹178.01
Change in Liabilities₹210.45-₹4.80₹88.78₹74.26
Change in WC-₹108.97-₹122.28-₹139.44-₹103.75
Cash flow from Operations₹523.24₹432.37₹318.39₹271.37
Cash flow from Investing-₹582.30-₹334.73-₹320.04-₹217.58
Cash flow from Financing-₹46.46-₹38.32-₹38.07-₹28.17
Total Cash Flow-₹105.52₹59.32-₹39.72₹25.62
Cash (Start of the year)₹199.45₹138.70₹177.56₹150.76
Cash (End of the year)₹94.18₹199.45₹138.70₹177.56

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,459.82₹1,073.90₹805.20₹639.21
Current Assets₹2,585.66₹2,133.95₹1,892.92₹1,552.19
Total Assets₹4,045.48₹3,207.85₹2,698.12₹2,191.40
Current Liabilities₹385.96₹305.99₹330.85₹268.00
Net Current Asset₹2,199.70₹1,827.96₹1,562.07₹1,284.19
Non-Current Liabilities₹28.72₹15.47₹20.44₹16.13
Equity Capital₹3,630.80₹2,886.39₹2,346.83₹1,907.27
Total Equity & Liabilities₹4,045.48₹3,207.85₹2,698.12₹2,191.40

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹738.33₹752.41₹625.09₹528.61
Other Income₹195.37₹134.59₹105.84₹99.00
Total Revenue₹933.70₹887.00₹730.93₹627.61
Total Expenses₹426.18₹445.33₹365.19₹334.46
Profit Before Tax₹507.52₹441.67₹365.74₹293.15
Tax₹110.94₹102.18₹82.03₹58.89
Profit After Tax₹396.58₹339.49₹283.71₹234.26
EPS - Basic₹52.17₹44.67₹37.36₹30.89
EPS - Diluted₹52.02₹44.67₹37.18₹30.62

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹507.52₹441.67₹365.74₹293.15
Income before WC changes₹363.71₹357.20₹297.17₹233.58
Change in Assets-₹99.88-₹36.74-₹74.52-₹54.85
Change in Liabilities₹49.06-₹20.75-₹24.55₹43.41
Change in WC-₹50.82-₹57.49-₹99.07-₹11.44
Cash flow from Operations₹203.48₹195.87₹111.01₹157.10
Cash flow from Investing-₹213.47-₹140.20-₹118.94-₹86.67
Cash flow from Financing-₹45.81-₹38.10-₹34.26-₹30.42
Total Cash Flow-₹55.80₹17.57-₹42.19₹40.01
Cash (Start of the year)₹99.64₹80.64₹122.02₹81.01
Cash (End of the year)₹44.09₹99.64₹80.64₹122.02

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,235.86₹988.79₹819.21₹641.48
Current Assets₹975.88₹825.69₹703.10₹661.70
Total Assets₹2,211.74₹1,814.48₹1,522.31₹1,303.18
Current Liabilities₹144.17₹99.85₹118.87₹146.85
Net Current Asset₹831.71₹725.84₹584.23₹514.85
Non-Current Liabilities₹17.07₹13.70₹13.29₹16.42
Equity Capital₹2,050.50₹1,700.93₹1,390.15₹1,139.91
Total Equity & Liabilities₹2,211.74₹1,814.48₹1,522.31₹1,303.18
* All values are in INR Crore
Caplin Point Lab market depth
Bid quantityBid priceAsk priceAsk quantity
002325.642
0000
0000
0000
0000
Total bid quantity0
Total ask quantity42
Caplin Point Lab technical summary
Bearish indicators3
Neutral indicators5
Bullish indicators0
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
40.08
Neutral
ATR (14)
81.09
Neutral
STOCH(9,6)
60.68
Neutral
STOCH RSI (14)
79.6
Bearish
ADX(9)
35.63
Bearish
UO(9)
50.18
Neutral
ROC(12)
-1.52
Bearish
WillR(14)
-47.49
Neutral
Period
Simple value
Exponential vaue
5D
2338.16
2332.7
10D
2294.36
2337.24
20D
2396.96
2399.68
50D
2568.97
2490.8
100D
2548.68
2436.38
Volume trend — traded volume by day
30 Oct1L
29 Oct0L
28 Oct0L
27 Oct0L
26 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Caplin Point Lab
Pharmaceuticals
Add Stock
Add Another

Mutual Funds Invested in Caplin Point Lab

Fund name
AUM
UTI Healthcare Fund
2.23%
UTI Small Cap Fund
1.41%
UTI Multi Cap Fund
1.41%

Caplin Point Lab Returns Calculator

Ex-date: 18 Sep 2026
Ex-date: 29 May 2026

Caplin Point Lab Latest News

1 month ago
Max Financial Services, Vardhman Textiles, Caplin Point shares spurt amid spike in volumes
2 months ago
Vardhman Textiles, Graphite India, Engineers India shares surge amid spike in volumes; check full list
2 months ago
Stocks to watch, August 24: Natco Pharma, M&M, RIL, Senco Gold, Caplin Point, real estate stocks, Grasim
Showing news item 1 of 3

Top Gainers

LAURUSLABS Share Price
₹2405.50
+161.5 (+7.2%)
TRENT Share Price
₹3017.30
+155.6 (+5.44%)
ZYDUSLIFE Share Price
₹1245.50
+61.1 (+5.16%)
NAVINFLUOR Share Price
₹8680.00
+419.5 (+5.08%)
POONAWALLA Share Price
₹461.70
+20.2 (+4.58%)
See more

Top Losers

INTELLECT Share Price
₹504.55
-98.3 (-16.31%)
REDINGTON Share Price
₹326.95
-30.2 (-8.46%)
SUZLON Share Price
₹33.90
-2.89 (-7.86%)
COHANCE Share Price
₹444.30
-37.05 (-7.7%)
PNCINFRA Share Price
₹123.93
-10.05 (-7.5%)
See more

Caplin Point Lab Share Price FAQs

Please be aware that Caplin Point Lab stock prices are subject to continuous fluctuations due to various factors.